Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
15 hedge funds and large institutions have $12.4M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
25% more capital invested
Capital invested by funds: $9.87M → $12.4M (+$2.5M)
25% more funds holding
Funds holding: 12 → 15 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.09% less ownership
Funds ownership: 53.28% → 44.18% (-9.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOCH
Blue Owl Capital Holdings
New York
|
+$464K |
| 2 |
JP Morgan Chase
New York
|
+$359K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$349K |
| 4 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$323K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$88.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.57M |
| 2 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
-$1.15M |
FRLN Hedge Fund Activity: Q4 2023 in Review
15 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q4 2023, worth a combined $12.4M — up 25% from $9.87M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FRLN positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $464K. The largest seller was Millennium Management, exiting entirely with an estimated $1.57M sold.
- 15 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q4 2023, up from 12 in Q3 2023.
- Funds reported $12.4M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q4 2023, up 25% quarter-over-quarter.
- 6 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q4 2023 and 2 closed out, a net change of +4 holders.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $464K added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q4 2023 was Millennium Management, an estimated $1.57M sold.
Based on aggregated 13F filings for Q4 2023.